Suppr超能文献

COVID-19 疫苗接种与勃起功能障碍风险增加无关。

COVID-19 vaccination not associated with increased risk of erectile dysfunction.

机构信息

Department of Urology, University of Miami, Miami, Florida, USA.

School of Medicine, University of Miami Miller, Miami, Florida, USA.

出版信息

Andrologia. 2022 Nov;54(10):e14563. doi: 10.1111/and.14563. Epub 2022 Sep 8.

Abstract

Although mRNA COVID-19 vaccines have proven to be safe and effective against SARS-CoV-2, vaccination rates have slowed, with some individuals citing impotence as a concern. Therefore, we conducted a survey of the US males to evaluate the impact of COVID-19 vaccination on erectile function. We hypothesized that vaccinated men would not have a higher risk of ED compared to unvaccinated men. Amazon Mechanical Turk (MTurk) was utilized to survey the US adult male population between August 26 and September 2, 2021. Survey participation was open to 1000 males over the age of 18 and currently living in the United States regardless of vaccination status or the past medical history of COVID-19. Selection criteria included respondents ≥45 years old, no history of physician-diagnosed ED, biologically born, and identify as male. Participants completed an anonymous 16-question survey that included a multidimensional scale used to evaluate ED, the International Index of Erectile Function (IIEF-5). Among vaccinated men, the median IIEF-5 score was 20 [16-24] compared to 22 [17.5-25] in the unvaccinated group (p = 0.195). The multivariable-adjusted analysis demonstrated that vaccination against COVID-19 was not associated with increased risk of ED. Overall, this cross-sectional survey showed that COVID-19 vaccination was not associated with an increased risk of erectile dysfunction in males 45 years and older.

摘要

尽管 mRNA COVID-19 疫苗已被证明可安全有效地预防 SARS-CoV-2,但疫苗接种率有所放缓,部分人表示担心阳痿。因此,我们对美国男性进行了一项调查,以评估 COVID-19 疫苗接种对勃起功能的影响。我们假设接种疫苗的男性与未接种疫苗的男性相比,勃起功能障碍(ED)的风险不会更高。我们利用亚马逊 Mechanical Turk(MTurk)于 2021 年 8 月 26 日至 9 月 2 日期间调查了美国成年男性人群。调查对年龄在 18 岁及以上、目前居住在美国、无论接种状况或过去是否有 COVID-19 病史的 1000 名男性开放。入选标准包括受访者年龄≥45 岁、无医生诊断的 ED 病史、为生物学男性、且自我认同为男性。参与者完成了一份匿名的 16 个问题的调查,其中包括一个多维量表,用于评估 ED,即国际勃起功能指数(IIEF-5)。在接种疫苗的男性中,IIEF-5 评分的中位数为 20 [16-24],而未接种疫苗的男性为 22 [17.5-25](p=0.195)。多变量调整分析表明,COVID-19 疫苗接种与 ED 风险增加无关。总体而言,这项横断面调查显示,45 岁及以上男性 COVID-19 疫苗接种与勃起功能障碍风险增加无关。

相似文献

本文引用的文献

2
Increased odds ratio for erectile dysfunction in COVID-19 patients.新冠肺炎患者勃起功能障碍的优势比增加。
J Endocrinol Invest. 2022 Apr;45(4):859-864. doi: 10.1007/s40618-021-01717-y. Epub 2021 Nov 30.
3
Impact of the SARS-CoV-2 virus on male reproductive health.新型冠状病毒对男性生殖健康的影响。
BJU Int. 2022 Feb;129(2):143-150. doi: 10.1111/bju.15573. Epub 2021 Aug 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验